You are here: Industry Insights > influenza vaccine

News List

Covid-19 Oral Medicine -- a Link to be focused on Against Epidemic PharmaSources/Chuxin
July 26, 2021
In the wake of the outbreak of the COVID-19, the globally cumulative infected population has capped 100 million, which poses a huge impact on human activities.
Phase I trial of mRNA-based influenza vaccine begins europeanpharmaceuticalreview
June 24, 2021
The trial will assess a monovalent mRNA-based vaccine candidate against seasonal influenza caused by the A/H3N2 strain.
Influenza Vaccine and Novavax COVID-19 Vaccine Simultaneous Administration Yields Positive Results americanpharmaceuticalreview
June 17, 2021
Novavax Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced data from the first co-administration study of a SARS-CoV-2 vaccine candidate [Novavax, NVX-CoV2373] and an approved influenza vaccine ...
What strains should be in this year’s seasonal influenza vaccines? europeanpharmaceuticalreview
March 31, 2021
The European Medicines Agency has published its recommendations for 2021-2022 seasonal influenza vaccine composition.
Intravacc and Versatope to develop universal influenza vaccine based on OMV technology expresspharma
June 09, 2020
According to Centers for Disease Control and Prevention, influenza vaccines were overall 29 per cent effective during the 2018–2019 influenza season due to the emergence of new, late season viral strains.
Emergent Signs Manufacturing Agreement with Novavax contractpharma
April 06, 2020
Emergent BioSolutions has entered an agreement with Novavax to provide molecule-to-market contract development and manufacturing services to produce Novavax’s NanoFlu.
A Next Generation Sequencing (NGS) Approach to Influenza Vaccine Development fiercepharma
August 25, 2019
Influenza is a seasonal disease. It fluctuates in a very typical manner, and probably has for centuries, but certainly for decades since it’s been monitored.
FDA Approves Use of Fluzone Quadrivalent in Children as Young as 6 Months americanpharmaceuticalreview
January 25, 2019
The U.S. Food and Drug Administration (FDA) has approved the use of the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) to include children age 6 months through 35 months....
Anti-vaccine sentiment causing deaths, subjecting women to cervical cancer, expert says fiercepharma
December 06, 2018
In recent years, the anti-vaccine movement has gained steam and attracted a growing number of headlines. Now, a vaccine expert says the movement is starting to result in its first deaths.
BiondVax relocates to new manufacturing facility biospectrumasia
August 21, 2018
BiondVax Pharmaceuticals Ltd. recently reported the company's relocation to a newly constructed mid-size commercial scale manufacturing facility in Jerusalem, Israel.

Previous page 1 2 Next page